Dr. Parikh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
67 E 78th St
New York, NY 10075Phone+1 212-744-2513
Education & Training
- Yale-New Haven Medical CenterResidency, Ophthalmology, 2014 - 2017
- Vanderbilt University School of MedicineClass of 2013
Certifications & Licensure
- MA State Medical License 2018 - 2025
- NY State Medical License 2016 - 2025
- American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- Reply to Comment On: Impact of GLP-1 Agonists and SGLT-2 Inhibitors on Diabetic Retinopathy Progression: An Aggregated Electronic Health Record Data Study.Karen M Wai, Kapil Mishra, Euna Koo, Cassie Ann Ludwig, Ravi Parikh
American Journal of Ophthalmology. 2024-12-01 - Cost analysis of dropless cataract surgery prophylaxis with intracameral antibiotics and subconjunctival steroids.Scott Massa, David J Smits, Alexander T Nguyen, Sachi A Patil, Evan M Chen
Journal of Cataract and Refractive Surgery. 2024-12-01 - 1 citationsInitial Therapy of Panretinal Photocoagulation vs Anti-VEGF Injection for Proliferative Diabetic Retinopathy.Amer F Alsoudi, Karen M Wai, Euna Koo, Ravi Parikh, Prithvi Mruthyunjaya
JAMA Ophthalmology. 2024-10-01
Press Mentions
- Slow Start for AI-Assisted Screening for Diabetic Retinopathy Despite PromiseNovember 8th, 2024
- Approval of Bevacizumab Biosimilar for Ophthalmic Use Could Upend Low-Cost Anti-VEGFOctober 24th, 2024
- Penn Medicine to Present Multiple Clinical Trial Results at 2024 ASCO Annual MeetingMay 29th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: